Early results show that a new combination drug therapy is safe and effective against advanced skin cancer in patients who were not able to have their tumors surgically removed. The drug combination is among the first, researchers say, to demonstrate the potential value of a live common ...
Lung cancer causes more deaths in the United States than any other form of cancer, killing eighty percent of those who get it and more than breast, colon and prostate cancers combined. It takes more than 160,000 lives each year in the U.S. But, reportsCBS News correspondent Michelle Giela...
It took more than 14 years but the bet could be paying off.In February,Shenzhen Chipscreen Biosciences' first therapy,a medication for a rare type of lymph-node cancer,hit the market in China. The willingness of veterans like Dr.Lu and others to leave multinational drug companies for Chinese...
The plant would be rewired so that instead of making trace amounts of the drug, it would make lots of it. The technology is still about a decade away from being a viable commercial use, he says. "The issue to overcome is scaling up," he says. "You need to grow the plants...
“Traditional adult cancer drugs don’t work well in kids because children are still developing and their normal cells divide at a rapid pace,” said Mitra. “This drug combination could potentially help not only minimize the negative impacts of traditional cancer treatment in kids but also give...
A. whatever B. whoever C. wherever D. whichever 5(2013·江苏,28)In the global economy,a new drug for cancer,___it is discovered,will create many economic possibilities around the world. A. whatever B. whoever C. wherever D. whichever 反馈 收藏...
This joint project integrated a pioneering new gene-editing technique developed by the Christiana Care Gene Editing Institute into NevellusDX’s cancer diagnostic process. It led NovellusDx to identify a specific drug as a candidate to treat various types of cancer. ...
“Using the PSMA molecule to directly target prostate cancer cells is the beginning of a new era of precision medicine in urology diagnostics as well as therapy”, says Professor Peter Albers, Head of the Department of Urology, Dusseldorf University, and Chair of the Scientific Office of the EA...
The researchers, however, found that the hyperactive resistant melanoma cells produced large amounts of reactive oxygen species, but cancer cells that were still sensitive to the drug did not do this. Reactive oxygen species is a double-edged sword, according to the researchers. They play an imp...